{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:56:10Z","timestamp":1776257770502,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.4158\/e161332.or","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T16:06:54Z","timestamp":1480349214000},"page":"1296-1302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevelence of Primary Aldosteronism in an Urban Hypertensive Population"],"prefix":"10.1016","volume":"22","author":[{"given":"Sandi-Jo","family":"Galati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadeen C.","family":"Cheesman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Springer-Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Krakoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Bagiella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel A.","family":"Zhuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany K.","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsey","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Boyajian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"W.B.","family":"Inabnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice C.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/E161332.OR_bb0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.4158\/E161332.OR_bb0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ajh.2010.169","article-title":"Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment","volume":"23","author":"Sechi","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.4158\/E161332.OR_bb0020","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/E161332.OR_bb0025","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/E161332.OR_bb0030","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","article-title":"Secondary hypertension in a blood pressure clinic","volume":"147","author":"Sinclair","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.4158\/E161332.OR_bb0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.4158\/E161332.OR_bb0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/E161332.OR_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.4158\/E161332.OR_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.4158\/E161332.OR_bb0055","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/E161332.OR_bb0060","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/E161332.OR_bb0065","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/E161332.OR_bb0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","article-title":"Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia","volume":"20","author":"Williams","year":"2006","journal-title":"J Hum Hypertens"},{"key":"10.4158\/E161332.OR_bb0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.4158\/E161332.OR_bb0080","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.4158\/E161332.OR_bb0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.4158\/E161332.OR_bb0090","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.4158\/E161332.OR_bb0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1479164109350556","article-title":"Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism","volume":"7","author":"Mukherjee","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.4158\/E161332.OR_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10641963.2012.712175","article-title":"Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia","volume":"35","author":"Li","year":"2013","journal-title":"Clin Exp Hypertens"},{"key":"10.4158\/E161332.OR_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Reninangiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.4158\/E161332.OR_bb0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","article-title":"Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects","volume":"34","author":"Ito","year":"2011","journal-title":"Hypertens Res"},{"key":"10.4158\/E161332.OR_bb0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/02813430600830931","article-title":"High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden","volume":"24","author":"Westerdahl","year":"2006","journal-title":"Scand J Prim Health Care"},{"key":"10.4158\/E161332.OR_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7861\/clinmedicine.5-1-55","article-title":"Prevalence of primary hyperaldosteronism assessed by aldosterone\/renin ratio and spironolactone testing","volume":"5","author":"Hood","year":"2005","journal-title":"Clin Med (Lond)"},{"key":"10.4158\/E161332.OR_bb0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1470320312463833","article-title":"Screening for primary aldosteronism in a primary care unit","volume":"14","author":"Volpe","year":"2013","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.4158\/E161332.OR_bb0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.4158\/E161332.OR_bb0135","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/E161332.OR_bb0140","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline","author":"Funder","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/E161332.OR_bb0145","first-page":"39","article-title":"Laboratory investigation of primary aldosteronism","volume":"31","author":"Stowasser","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"10.4158\/E161332.OR_bb0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clin Chem"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:59:30Z","timestamp":1761515970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20355816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1530891X20355816"],"URL":"https:\/\/doi.org\/10.4158\/e161332.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevelence of Primary Aldosteronism in an Urban Hypertensive Population","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/E161332.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}